AU2001243349A1 - Methods for the diagnosis and treatment of breast cancer - Google Patents

Methods for the diagnosis and treatment of breast cancer

Info

Publication number
AU2001243349A1
AU2001243349A1 AU2001243349A AU4334901A AU2001243349A1 AU 2001243349 A1 AU2001243349 A1 AU 2001243349A1 AU 2001243349 A AU2001243349 A AU 2001243349A AU 4334901 A AU4334901 A AU 4334901A AU 2001243349 A1 AU2001243349 A1 AU 2001243349A1
Authority
AU
Australia
Prior art keywords
diagnosis
treatment
methods
breast cancer
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001243349A
Inventor
Nancy Carrasco
Orsolya Dohan
Uygar H. Tazebay
Irene L. Wapnir
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Medicine and Dentistry of New Jersey
Albert Einstein College of Medicine
Original Assignee
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Albert Einstein College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Medicine and Dentistry of New Jersey, Rutgers State University of New Jersey, Albert Einstein College of Medicine filed Critical University of Medicine and Dentistry of New Jersey
Publication of AU2001243349A1 publication Critical patent/AU2001243349A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
AU2001243349A 2000-03-07 2001-03-01 Methods for the diagnosis and treatment of breast cancer Abandoned AU2001243349A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/519,959 US6821725B1 (en) 2000-03-07 2000-03-07 Methods for the diagnosis and treatment of breast cancer
US09519959 2000-03-07
PCT/US2001/006548 WO2001065998A2 (en) 2000-03-07 2001-03-01 Methods for the diagnosis and treatment of breast cancer

Publications (1)

Publication Number Publication Date
AU2001243349A1 true AU2001243349A1 (en) 2001-09-17

Family

ID=24070583

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001243349A Abandoned AU2001243349A1 (en) 2000-03-07 2001-03-01 Methods for the diagnosis and treatment of breast cancer

Country Status (3)

Country Link
US (2) US6821725B1 (en)
AU (1) AU2001243349A1 (en)
WO (1) WO2001065998A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709613B2 (en) * 2002-11-18 2010-05-04 Albert Einstein College Of Medicine Of Yeshiva University Rhenium-188 and rhenium-186 for treatment of tumors expressing a Na+/I− symporter
WO2006058334A2 (en) * 2004-11-29 2006-06-01 Perkinelmer Life And Analytical Sciences Prticle-based multiplex assay for identifying glycosylation
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US20100160275A1 (en) * 2006-09-26 2010-06-24 Lee Eva Y H P Methods and compositions for cancer prevention and treatment
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9951117B2 (en) 2010-09-02 2018-04-24 Mayo Foundation For Medical Education And Research Vesicular stomatitis viruses
WO2014197069A2 (en) * 2013-03-15 2014-12-11 Mayo Foundation For Medical Education And Research Radiotracer imaging using sodium iodide symporter polypeptides
WO2020243240A1 (en) * 2019-05-28 2020-12-03 Case Western Reserve University Compositions and methods for preserving dna methylation

Also Published As

Publication number Publication date
US20060014160A1 (en) 2006-01-19
WO2001065998A2 (en) 2001-09-13
US6821725B1 (en) 2004-11-23
WO2001065998A3 (en) 2002-02-28
US7303740B2 (en) 2007-12-04

Similar Documents

Publication Publication Date Title
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
GB9903841D0 (en) Diagnosis and treatment of cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
HUP0201757A3 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU2002348297A1 (en) Proteonomic methods for diagnosis and monitoring of breast cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
PL366066A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3177500A (en) Proteins for diagnosis and treatment of breast cancer
ZA200108256B (en) Compositions and methods for the treatment and diagnosis of breast cancer.
HUP0200825A2 (en) Compositions and methods for the treatment and diagnosis of breast cancer